Zenti 150 Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info

Concise Prescribing Info

Contents

Ranitidine HCl

Indications/Uses

Gastric & duodenal ulcer, reflux oesophagitis & pathological hypersecretion of gastric acid conditions eg, Zollinger-Ellison’s syndrome, systemic mastocytosis.

Dosage/Direction for Use

Adult Gastric, duonenal ulcer, reflux esophagitis 150 mg twice daily, in the morning & night, or 300 mg once daily before bedtime for 4-8 wk. Maintenance: 150 mg daily before bedtime. Prophylaxis of peptic ulcer 150 mg twice daily. Zollinger-Ellison’s syndrome Initially 150 mg twice daily.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity.

Special Precautions

Patients w/ acute porphyria. Impaired liver & kidney function. Pregnancy & lactation. Childn.

Adverse Reactions

Occasionally, headache, dizziness, malaise, myalgia, nausea, diarrhea, pruritus, constipation, abdominal pain. Confusion, gynecomastia, hyperprolactinemia, sexual dysfunction, bradycardia. Insomnia, hallucination, vomiting, skin rash (rare), leukopenia, granulocytopenia, thrombocytopenia.

View ADR Monitoring Form

Drug Interactions

Warfarin.

MIMS Class

Antacids, Antireflux Agents & Antiulcerants

ATC Classification

A02BA02 - ranitidine ; Belongs to the class of H2-receptor antagonists. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).

Regulatory Classification

Presentation/Packing

Form

Zenti 150 FC tab 150 mg

Packing/Price

10 × 10's (Rp519,365/boks)

Zenti 150

ranitidine

Manufacturer:

Zenith Pharmaceuticals